Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)

Published:2022-03-16 Issue:8 Volume:57 Page:978-983
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Hagström Hannes¹²^ORCID,Shang Ying²,Wester Axel²,Widman Linnea²³

Affiliation:

1. Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden

2. Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden

3. Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2022.2051202

Reference16 articles.

1. Selection Bias Due to Loss to Follow Up in Cohort Studies

2. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

3. A comparison of fibrosis progression in chronic liver diseases

4. The Swedish cause of death register

5. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction‐associated steatotic liver disease;Liver International;2024-09-02

2. Metabolic dysfunction‐associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study;International Journal of Cancer;2024-07-17

3. Reply;Clinical Gastroenterology and Hepatology;2024-05

4. Statin initiation after myocardial infarction in patients with alcohol‐related liver disease: A nationwide population‐based study;Liver International;2024-04-23

5. Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes;Gut;2024-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3